
Prime Medicine Stock Surges After Favorable Arbitration Ruling
Shares of Prime Medicine rose sharply after the company announced a favorable binding arbitration ruling in a dispute with Beam Therapeutics over a key gene editing therapy. The decision resolves a significant legal uncertainty and clears the path for the drug's clinical development.







